# Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

> **NCT00447070** · PHASE4 · COMPLETED · sponsor: **Foundation for Cardiovascular Research, Zurich** · enrollment: 50 (—)

## Conditions studied

- HIV Infections
- Dyslipidemia

## Interventions

- **DRUG:** ATAZANAVIR

## Key facts

- **NCT ID:** NCT00447070
- **Lead sponsor:** Foundation for Cardiovascular Research, Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 50 (—)
- **Last updated:** 2009-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447070, "Effect of Atazanavir on Endothelial Function in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00447070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*